|
[1]
|
van Heek NT, Meeker AK, Kern SE, et al. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia[J]. Am J Pathol, 2002, 161:1541-1547. doi: 10.1016/S0002-9440(10)64432-X |
|
[2]
|
吴易阳, 李岭. MicroRNA与肿瘤相关的信号转导通路[J].遗传, 2007, 29:1419-1428. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=yc200712002 |
|
[3]
|
Lee RC, Feinbaum RL, Ambros V. The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to line-14[J]. Cell, 1993, 75:843-854. doi: 10.1016/0092-8674(93)90529-Y |
|
[4]
|
Pasquinelli A, Reinhart B, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA[J]. Nature, 2000, 408:86-89. doi: 10.1038/35040556 |
|
[5]
|
Meister G, Landthaler M, Patkaniowska A, et al. Human Argonaute 2 mediates RNA cleavage targeted by miRNAs and siRNAs[J]. Mol Cell, 2004, 15:185-197. doi: 10.1016/j.molcel.2004.07.007 |
|
[6]
|
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J]. Cell, 2005, 120:15-20. doi: 10.1016/j.cell.2004.12.035 |
|
[7]
|
John B, Enright AJ, Aravin A, et al. Human MicroRNA targets[J]. PLoS Biol, 2004, 2:e363. doi: 10.1371/journal.pbio.0020363 |
|
[8]
|
Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior[J]. J Clin Oncol, 2006, 24:4677-4684. doi: 10.1200/JCO.2005.05.5194 |
|
[9]
|
Wan C, Shen Y, Yang T, et al. Diagnostic value of micro-RNA for pancreatic cancer:a meta-analysis[J]. Arch Med Sci, 2012, 8:749-755. |
|
[10]
|
Habbe N, Koorstra JB, Mendell JT. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia[J]. Cancer Biol Ther, 2009, 8:340-346. doi: 10.4161/cbt.8.4.7338 |
|
[11]
|
Ryu JK, Hong SM, Karikari CA, et al. Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma[J]. Pancreatology, 2010, 10:66-73. doi: 10.1159/000231984 |
|
[12]
|
Yu J, Li A, Hong SM. MicroRNA alterations of pancreatic intraepithelial neoplasias[J]. Clin Cancer Res, 2012, 18:981-992. doi: 10.1158/1078-0432.CCR-11-2347 |
|
[13]
|
Remmers N, Bailey JM, Mohr AM. Molecular pathology of early pancreatic cancer[J]. Cancer Biomark, 2010, 9:421-440. http://www.ncbi.nlm.nih.gov/pubmed/22112488/ |
|
[14]
|
Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma[J]. Oncogene, 2007, 26:4442-4452. doi: 10.1038/sj.onc.1210228 |
|
[15]
|
Yabushita S, Fukamachi K, Tanaka H, et al. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas[J]. Pancreas, 2012, 41:1013-1018. doi: 10.1097/MPA.0b013e31824ac3a5 |
|
[16]
|
Morimura R, Komatsu S, Ichikawa D, et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer[J]. Br J Cancer, 2011, 105:1733-1740. doi: 10.1038/bjc.2011.453 |
|
[17]
|
Ho AS, Huang X, Cao H, et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer[J]. Transl Oncol, 2010, 3:109-113. doi: 10.1593/tlo.09256 |
|
[18]
|
Sadakari Y, Ohtsuka T, Ohuchida K, et al. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma[J]. JOP, 2010, 11:587-592. http://www.ncbi.nlm.nih.gov/pubmed/21068491 |
|
[19]
|
Ren Y, Gao J, Liu JQ, et al. Differential signature of fecal microRNAs in patients with pancreatic cancer[J]. Mol Med Report, 2012, 6:201-209. http://www.ncbi.nlm.nih.gov/pubmed/22504911 |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
